Abstract
Most skin disorders are not fatal but most people are affected globally. The
revenue of dermatological market in 2006 was $16bn, which is a 5.1% when
compared with 2003. The common skin disorders include acne, dermatitis,
psoriasis, rosacea, urticaria and hair loss. Due to the aesthetic awareness
increases in Western countries, botulinum toxin and other cosmetic treatments
become more and more popular.
The treatment of dermatological disorders are often a cause for concern. Users
are keen to benefit from the treatments, often to the point were they overlook
possible health concerns. In 2006 September, the FDA launched the iPledge
program to prevent birth defects caused by use of isotretinoin during
pregnancies. In addition, Roaccutane, an isotretinoin agent for acne, might
disrupts serotonin to cause a range of aggression, anger and sleep, according
to the study from University of Bath in the UK - this is not the first time
studies have shown Roaccutane to be dangerous to some.
This skin disorder report contains:
- The prevalence of skin disorder and the number of cosmetic procedures: It
includes the prevalence in the seven major markets.
- The current treatments and future potential treatments as well as drug
delivery technologies.
- Current market analysis, including topical and systemic dermatological
treatments. The analysis contains the strategic analysis of sales performance,
market share and sales forecast to 2012, 2017 and 2022
- Key players analysis, including the analysis of the product portfolio, R&D
and the analyses of strategies.
- Porter-Five-Forces Analysis and SWOT analysis to offer the understanding
of the strategic issues will impact on dermatological market
Key Market for the Future
Visiongain predicts that the retail market for dermatological treatments will
continue to show significant growth for what is an already large market.
Corticosteroid agents will still be the main sales drivers to dermatological
market whilst botulinum toxin and other cosmetic treatments will be more
significant during the forecast period.
Why You Should Buy This Report
- Dermatological treatments is a important therapeutic area which have
significant impact to most population globally
- Which treatments are the most efficient for acne, psoriasis and other
dermatological conditions? Does any safety concern occur on those treatments?
This report will not only answer those questions but also give you the
comprehensive view on the patients' perception for those treatments.
- Corticosteroid agents are widely used on skin disorder due to its potent
effect. This report will help you top assess just what impact that this is
likely to have.
- Cosmetic procedures become more significant in the recent years, including
the treatments of botulinum toxin and hyaluronic acid. Visiongain will tell
the market performance and impact of those products.
- Visiongain has taken the latest available financial and prevalence
statistics with forecast revenue figures for each dermatological treatment,
all the leading products and blockbusters to 2012 or 2022.
- The report contains strategic analysis of the pipeline, in addition, the
current market and strategies analysis for key players.
Why You Must Buy This Report?
This report features news, insights, the latest developments and an in depth
survey of the pain market with up-to-date analysis as well as tables, graphs
and charts. This report is a vital addition to gaining an understanding of
this market sector and will give your company ' the edge' on your competitors.
You can not afford to be without this latest report from visiongain.
Unique benefits to you when you order this report
- You can access your report whichever country you are in without using
harddrive space
- Primary research throughout. You will not find this information anywhere
else
- Report stored in your reading room for ever
- Full searchable report when you buy the company or corporate editions
- Copies can be printed off for offline reading
- Packed with charts, analysis, figures, graphs and tables
| 
View Cart
